1 study on Gpr38 mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
**The identification of `GPR38` as a GHS-R family member with motilin as its ligand** reveals that GH secretagogue pharmacology is entangled with gut-motility signaling — a consideration for clinicians and researchers…